PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1705883
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1705883
Global Lung Stent Market is estimated to be valued at USD 250.6 Mn in 2025 and is expected to reach USD 410.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 250.6 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 7.30% | 2032 Value Projection: | USD 410.4 Mn |
The lung stent market has been witnessing steady growth over the past few years, mainly due to the increasing prevalence of chronic respiratory diseases globally. Lung stents are small mesh tubes inserted into the airways of the lungs through minimally invasive procedures to relieve blockages. They play a vital role in improving breathing by keeping constricted or collapsed airways open. Growing geriatric populations who are more prone to chronic lung disorders (including lung cancer, chronic obstructive pulmonary disease (COPD), congenital malformations, and injuries) combined with rising air pollution levels in both developed and developing nations have been augmenting the demand for lung stents. However, the risk of complications associated with lung stents and the availability of alternative treatment options may hamper market expansion to some extent.
The global lung stent market is driven by the growing geriatric population susceptible to chronic lung diseases, increasing pollution levels leading to higher respiratory infections and disorders, and the rising prevalence of lung cancer. According to the World Health Organization, COPD affected over 65 million people globally in 2021 and caused over 3 million deaths. Additionally, technological advances facilitating minimally invasive stent placement through advanced delivery systems and accurate placement are further broadening the market potential. However, high costs associated with lung stenting procedures and product development by manufacturers, as well as post-procedure complications like stent migration, are some of the major factors expected to hinder market growth. Meanwhile, ongoing research and development focusing on bioabsorbable stents and 3D-printed customized stents offer lucrative opportunities for lung stent providers.